Social support, psychological distress, and natural killer cell activity in ovarian cancer

Journal of Clinical Oncology

Volumn 23, Issue 28, 2005, Pages 7105-7113

  Lutgendorf, Susan K ^a   Sood, Anil K ^a   Anderson, Barrie ^a   McGinn, Stephanie ^a   Maiseri, Heena ^a   Dao, Minh ^a   Sorosky, Joel I ^a   De Geest, Koen ^a   Ritchie, Justine ^a   Lubaroff, David M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES FLUID; BLOOD SAMPLING; CANCER SURGERY; CELL ACTIVITY; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL SUPPORT; TUMOR ASSOCIATED LEUKOCYTE; ASCITES; CASE CONTROL STUDY; IMMUNOLOGY; MENTAL STRESS; MIDDLE AGED; MONOCYTE; OVARY TUMOR; PSYCHOLOGICAL ASPECT;

ADULT; AGED; ASCITES; CASE-CONTROL STUDIES; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; MONOCYTES; OVARIAN NEOPLASMS; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 27244432584     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.10.015     Document Type: Article

References (59)

1. Andersen B, Anderson B, deProsse C: Controlled prospective longitudinal study of women with cancer: I. Psychological functioning and outcomes. J Consult Clin Psychol 57:683-691, 1989
2. Meyerowitz B: Psychosocial correlates of breast cancer and its treatments. Psychol Bull 87:108-131, 1980
3. Bodurka-Bevers D, Basen-Engquist K, Carmack C, et al: Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78:302-308, 2000
4. Norton TR, Manne SL, Rubin S, et al: Prevalence and predictors of psychological distress among women with ovarian cancer. J Clin Oncol 22:919-926, 2004
5. Anderson B: Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 70:590-610, 2002
6. Levy S, Herberman R, Lippman M, et al: Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5:348-353, 1987
7. Ben-Eliyahu S, Shakhar G, Page GG, et al: Suppression of NK cell activity and of resistance to metastasis by stress: A role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8:154-164, 2000
8. Irwin M: Psychoneuroimmunology of depression: Clinical implications. Brain Behav Immun 16:1-16, 2002
9. Fawzy FI, Kemeny ME, Fawzy NW, et al: A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Arch Gen Psychiatry 47:729-735, 1990
10. Ben-Eliyahu S, Page GG, Yimira R, et al: Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80:880-888, 1999
11. Cohen S, Wills T: Stress, social support, and the buffering hypothesis. Psychol Bull 98:310-357, 1985
12. House JS, Landis KR, Umberson D: Social relationships and health. Science 241:540-545, 1988
13. Baron R, Cutrona C, Hicklin D, et al: Social support and immune function among spouses of cancer patients. J Pers Soc Psychol 59:344-352, 1990
14. Levy S, Herberman R, Lee J, et al: Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Nat Immun Cell Growth Regul 9:313-324, 1990
15. Uchino B, Cacioppo J, Kiecolt-Glaser J: The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health. Psychol Bull 119:488-531, 1996
16. Levy S, Herberman R, Lippman M, et al: lmmunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 17:67-75, 1991
17. Goodwin PJ, Leszcz M, Ennis M, et al: The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719-1726, 2001
18. Cerwenka A, Lanier L: Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41-49, 2001
19. Garzetti G, Cignitti M, Ciavattini A, et al: Natural killer cell activity and progression-free survival in ovarian cancer. Gynecol Obstet Invest 35:118-120, 1993
20. Goedegebuure PS, Douville CC, Doherty JM, et al: Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. Cell Immunol 175:150-156, 1997
21. Goedegebuure P, Zuber M, Leonard-Vidal D, et al: Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: In vitro cytokine production is associated with in vitro efficacy. Surg Oncol 3:79-89, 1994
22. Lotzova E, Savary C, Freedman R, et al: Natural immunity against ovarian cancers. Comp Immunol Microbiol Infect Dis 9:269-275, 1986
23. Lotzova E, Savary C, Freedman R, et al: Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract. Cancer Immunol Immunother 17:124-129, 1984
24. Lai P, Rabinowich H, Crowley-Nowick P, et al: Alteration in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2:161-173, 1996
25. Rabinowich H, Suminami Y, Reichert TE, et al: Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int J Cancer 68:276-284, 1996
26. Schondorf T, Engel H, Lindemann C, et al: Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynecological tumours. Cancer Immunol Immunother 44:88-96, 1997
27. American Cancer Society: Cancer Facts and Figures. Atlanta, GA, American Cancer Society, 2005
28. Christensen A, Edwards D, Wiebe J, et al: Effect of verbal self-disclosure on natural killer cell activity: Moderating influence of cynical hostility. Psychosom Med 58:150-155, 1996
29. Sheeran TP, Jackson FR, Dawes PT, et al: Measurement of natural killer cell cytotoxicity by area under a cytotoxic curve: A method suitable for rheumatoid arthritis. J Immunol Methods 115:95-98, 1988
30. Cutrona CE, Russell DW: The provisions of social relationships and adaptation to stress, in Advances in Personal Relationships. Greenwich, CT, JAI Press, 1987, pp 37-67
31. Cutrona CE: Social support and stress in the transition to parenthood. J Abnorm Psychol 93:378-390, 1984
32. Russell D, Cutrona C, Rose J, et al: Social and emotional loneliness: An examination of Weiss's typology of loneliness. J Pers Soc Psychol 46:1313-1321, 1984
33. Curran SL, Andrykowski MA, Studts JL: Short Form of the Profile of Mood States (POMS-SF): Psychometric information. Psychol Assess 7:80-83, 1995
34. Sacham S: A shortened version of the Profile of Mood States. J Pers Assess 47:305-306, 1983
35. Cohen J: A power primer. Psychol Bull 112:155-159, 1992
36. Baron R, Kenny D: The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173-1182, 1986
37. Cohen S, Rabin B: Psychological stress, immunity, and cancer. J Natl Cancer Inst 90:3-4, 1998
38. Pawelec G: Immunotherapy and immunoselection: Tumour escape as the final hurdle. FEBS Lett 567:83-66, 2004
39. Ben-Eliyahu S: The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17:S27-S36, 2003 (suppl 1)
40. Shakhar G, Ben-Eliyahu S: Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients? Ann Surg Oncol 10:972-992, 2003
41. Andersen BL, Farrar WB, Golden-Kreutz D, et al: Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 90:30-36, 1998
42. McGregor B, Antoni M, Boyers A, et al: Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J Psychosom Res 56:1-8, 2004
43. Andersen BL, Farrar WB, Golden-Kreutz DM, et al: Psychological, behavioral, and immune changes after a psychological intervention: A clinical trial. J Clin Oncol 22:3570-3580, 2004
44. Dhabhar F, McEwen B: Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci U S A 96:1059-1064, 1999
45. Sanders V, Straub R: Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 16:290-332, 2002
46. Benschop R, Jacobs R, Sommer B, et al: Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB J 10:517-524, 1996
47. Gan X, Zhang L, Solomon G, et al: Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: Inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Brain Behav Immun 16:227-246, 2002
48. Elenkov I, Papanicolaou D, Wilder R, et al: Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc Assoc Am Physicians 108:374-381, 1996
49. Goodier MR, Londei M: Lipopolysaccharide stimulates the proliferation of human CD56+CD3-NK cells: A regulatory role of monocytes and IL-10. J Immunol 165:139-147, 2000
50. Lee JC, Lee KM, Kim DW, et al: Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172:7335-7340, 2004
51. Lutgendorf SK, Johnsen E, Cooper B, et al: Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95:808-815, 2002
52. Chen WS, Kitson RP, Goldfarb RH: Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). In Vivo 16:439445, 2002
53. Aguado LI: Role of the central and peripheral nervous system in the ovarian function. Microsc Res Tech 59:462-473, 2002
54. Kaufman B, Scharf O, Arbeit J, et al: Proceedings of the oxygen homeostasis/hypoxia meeting. Cancer Res 64:3350-3356, 2004
55. Xu L, Fukumura D, Jain RK: Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MARK signaling pathway: Mechanism of low pH-induced VEGF. J Biol Chem 277:11368-11374, 2002
56. Shi Q, Le X, Wang B, et al: Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene 20:3751-3756, 2001
57. Lee ZS, Critchley JA: Simultaneous measurement of catecholamines and kallikrein in urine using boric acid preservative. Clin Chim Acta 276:89-102, 1998
58. Cohen S, Kessler R, Gordon L: Measuring Stress: A Guide for Health and Social Scientists. New York, NY, Oxford University Press, 1997
59. Lutgendorf S, Anderson B, Larsen K, et al: Cognitive processing, social support coping, and distress in gynecologic cancer patients. Cancer Res Ther Control 8:123-137, 1999